| Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | $ 310.89K | $ 66.38K | $ 58.59K | $ 0.00 |
| Gross Profit | $ 34.66K | $ 43.82K | $ 29.40K | $ 0.00 |
| Operating Income | $ -67.81K | $ -139.57K | $ -21.80K | $ -113.28K |
| EBITDA | $ -59.91K | $ 29.76K | $ 207.59K | $ -113.28K |
| Net Income | $ -67.73K | $ -138.50K | $ -21.00K | $ -113.31K |
| Balance Sheet | ||||
| Cash & Short-Term Investments | $ 29.73K | $ 21.24K | $ 33.10K | $ 0.00 |
| Total Assets | $ 751.93K | $ 406.22K | $ 427.95K | $ 1.41K |
| Total Debt | $ 80.41K | $ 0.00 | $ 50.00K | $ 0.00 |
| Net Debt | $ 50.68K | $ -21.24K | $ 16.90K | $ 0.00 |
| Total Liabilities | $ 872.27K | $ 606.86K | $ 624.40K | $ 50.68K |
| Stockholders' Equity | $ -120.33K | $ -200.64K | $ -196.45K | $ -49.26K |
| Cash Flow | ||||
| Free Cash Flow | $ 0.00 | $ 0.00 | $ 162.87K | $ -62.64K |
| Operating Cash Flow | $ 14.91K | $ -199.27K | $ 391.44K | $ -62.64K |
| Investing Cash Flow | $ -159.45K | $ 22.68K | $ -228.57K | $ 0.00 |
| Financing Cash Flow | $ 153.03K | $ 164.72K | $ -131.18K | $ 64.05K |
Global Pharmatech Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.